Skip to content
Ayulex

Legal

Vulnerability disclosure policy

We welcome reports of security vulnerabilities in Ayulex products from researchers, customers and anyone else. This policy explains what is in scope, how to look for problems without harming patients or customers, and what we commit to in return.

Last updated 6 November 2026

How to report

Write to admin@ayulex.com with “Security” in the subject line. Please include:

  • the product and the address (URL) where the problem is;
  • what the vulnerability is, and what an attacker could do with it;
  • the steps to reproduce it, and any proof-of-concept code or screenshots;
  • how we can reach you, and whether you would like to be credited.

Never include patient data in a report, even as evidence. Describe what you could see instead.

What is in scope

  • www.ayulex.com, this website;
  • ai.ayulex.com, Ayulex AI;
  • clinic.ayulex.com, Ayulex Clinic;
  • hmis.ayulex.com, Ayulex HMIS, including its HL7 FHIR R4 interface.

Out of scope: services run by other companies that our products use (report those to the company concerned), and findings with no demonstrable security impact, such as reports from automated scanners that have not been confirmed, missing headers on their own, or self-XSS.

How to research responsibly

Our products hold real patients’ records, so the limits matter:

  • Use only accounts you own, or that you have the account holder’s permission to use.
  • Do not access, change or delete data that is not yours. If you come across patient or personal data, stop, do not keep or share it, and tell us straight away.
  • Do not run denial-of-service tests, or scans heavy enough to slow a service down for the clinicians using it.
  • Do not try social engineering, phishing or physical access against our staff, customers or offices.
  • Do not test the national systems our products connect to, such as ABDM. Report problems there to their operators.
  • Keep the details confidential until we have fixed the problem, or agreed a date with you to disclose it.

What we commit to

  • We will acknowledge your report, investigate it, and keep you informed of what we find.
  • We will tell you when the problem is fixed, and agree with you when the details can be published.
  • With your permission, we will credit you for the report.
  • We consider research carried out in good faith and in line with this policy to be authorised, and we will not pursue legal action against you for it.

We do not run a paid bug bounty.

More information

This policy is also listed in our security.txt file. How the products protect data is set out in the trust centre, and for hospital IT teams in the Ayulex HMIS technology and security overview.